Led by the Bill and Melinda Gates Foundation with partners investing US$125 million and coordinating with the World Health Organization, the COVID-19 Therapeutics Accelerator began in March, facilitating drug development researchers to rapidly identify, assess, develop, and scale up potential treatments.
ئێستا ئێمە لە ئاستی سێیەمینین لە ئاستەکانی بڵاوبونەوەداTico19 Tico19